Rodriguez-Pascau, L., Britti, E., Calap-Quintana, P., Dong, Y. N., Vergara, C., Delaspre, F., . . . Pizcueta, P. (2021). PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia.
Citación estilo ChicagoRodriguez-Pascau, Laura, et al. PPAR Gamma Agonist Leriglitazone Improves Frataxin-loss Impairments in Cellular and Animal Models of Friedreich Ataxia. 2021.
Cita MLARodriguez-Pascau, Laura, et al. PPAR Gamma Agonist Leriglitazone Improves Frataxin-loss Impairments in Cellular and Animal Models of Friedreich Ataxia. 2021.
Precaución: Estas citas no son 100% exactas.